November 1, 2024
Alpha emitters for cancer treatment
Menu
Alpha emitters for cancer treatment
Thor Medical will become the world leading supplier of alpha emitters for cancer therapy
Thor Medical is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium (Th-232).
The production process is based on a novel technology developed by Thor Medical that combines high efficiency and cost competitive structure with best in class environmental friendliness.
Radionuclide Therapy (RNT) or Radioligand Therapy (RLT) utilising alpha-particle emitters is a promising technology for cancer treatment with a strong growth.
Read moreWe are committed to provide all shareholders and potential investors with relevant financial information in a consistent and transparent manner. Here you will find relevant information about Thor Medical.
